ARCHIVES

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

This article is from The Cancer Letter archive.

Vol. 04 No. 09 | March 3, 1978

Download PDF Visit The Full Archive

Related Articles

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

November 29, 2013

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

May 23, 1980

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

MSK Withdraws Form Breast Cancer Nutrition Study Over Chemotherapy Issue; Program Still “Going Well”

June 21, 1985